XML 26 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating Activities      
Net Income (Loss) $ 1.3 $ 69.4 $ 65.1
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:      
Depreciation and amortization 54.1 56.9 58.3
Amortization of deferred financing fees 0.5 0.5 0.7
Loss on extinguishment of debt 9.4 11.4 43.1
Loss (gain) on sale or disposal of assets, net 0.6 (2.5) 1.9
Deferred income taxes 0.5 (9.7) 24.9
Stock-based compensation expense 14.0 11.5 8.8
Pension and postretirement (benefit) expense, net 14.4 47.1 (40.5)
Changes in operating assets and liabilities:      
Accounts receivable, net 21.7 (33.4) 21.3
Inventories, net 7.3 (34.9) 18.8
Accounts payable (19.2) 15.3 (33.2)
Other accrued expenses (21.7) 5.3 (8.8)
Deferred charges and prepaid expenses (19.6) (3.9) (2.6)
Pension and postretirement contributions and payments (45.5) (2.8) (5.4)
Other, net 22.5 (4.9) (17.9)
Net Cash Provided (Used) by Operating Activities 40.3 125.3 134.5
Investing Activities      
Capital expenditures (64.3) (51.6) (27.1)
Proceeds from government funding 53.5 0.0 0.0
Proceeds from disposals of property, plant and equipment 0.0 1.7 5.4
Net Cash Provided (Used) by Investing Activities (10.8) (49.9) (21.7)
Financing Activities      
Purchase of treasury shares (37.6) (32.6) (52.0)
Proceeds from exercise of stock options 1.4 2.8 8.0
Shares surrendered for employee taxes on stock compensation (15.5) (3.4) (2.0)
Repayments on convertible notes (17.2) (18.7) (67.6)
Debt issuance costs 0.0 0.0 (1.0)
Net Cash Provided (Used) by Financing Activities (68.9) (51.9) (114.6)
Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash (39.4) 23.5 (1.8)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 281.3 257.8 259.6
Cash, Cash Equivalents, and Restricted Cash at End of Period $ 241.9 $ 281.3 $ 257.8